Financials
- Market Capitalization 12.52 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
146.72
売上高対価格比率
3.28
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 711 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.60 USD | -2.64% | -5.42% | -5.70% | +34.39% | 14.97 B USD | ||
| 759 | EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | +3.46% | +39.47% | 13.49 B USD | ||
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +15.49% | +26.00% | 12.33 B USD | ||
| 810 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | -0.25% | +55.21% | 12.31 B USD |